Optiver Holding
AZN icon

Optiver Holding’s AstraZeneca AZN Stock Holding History

Optiver Holding’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$104M Buy
527,000
+365,350
+226% +$70.4M 0.04% 122
2025
Q4 		$29.7M Sell
161,650
-76,350
-32% -$13.4M 0.01% 209
2025
Q3 		$36.5M Sell
238,000
-183,750
-44% -$27.8M 0.01% 169
2025
Q2 		$58.9M Buy
421,750
+172,300
+69% +$24.1M 0.03% 100
2025
Q1 		$36.7M Buy
249,450
+16,250
+7% +$2.35M 0.02% 114
2024
Q4 		$30.6M Buy
233,200
+119,600
+105% +$16.7M 0.02% 124
2024
Q3 		$17.7M Sell
113,600
-97,550
-46% -$15.7M 0.01% 192
2024
Q2 		$32.9M Buy
211,150
+68,550
+48% +$10.3M 0.02% 178
2024
Q1 		$19.2M Sell
142,600
-6,300
-4% -$834K 0.01% 233
2023
Q4 		$20.1M Sell
148,900
-94,400
-39% -$12.3M 0.01% 226
2023
Q3 		$33M Sell
243,300
-475,300
-66% -$64.9M 0.02% 185
2023
Q2 		$103M Sell
718,600
-44,900
-6% -$6.61M 0.07% 92
2023
Q1 		$106M Buy
763,500
+264,500
+53% +$35.6M 0.08% 96
2022
Q4 		$67.7M Buy
499,000
+44,750
+10% +$5.61M 0.07% 110
2022
Q3 		$50.2M Buy
454,250
+33,000
+8% +$4.19M 0.04% 95
2022
Q2 		$55.4M Sell
421,250
-170,450
-29% -$22.4M 0.06% 73
2022
Q1 		$78.5M Sell
591,700
-456,050
-44% -$54.7M 0.08% 61
2021
Q4 		$124M Buy
1,047,750
+586,650
+127% +$69M 0.11% 60
2021
Q3 		$55.4M Buy
461,100
+201,050
+77% +$23.4M 0.05% 73
2021
Q2 		$31.2M Buy
+260,050
New +$28.5M 0.04% 78
2021
Q1 		– Hold
0
– – – 74

Other funds holding AZN

IA
Investor AB Stockholm, Sweden $15.1B AUM 29.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
VAM
Vanguard Asset Management London, Ec4n 8af $117B AUM

Optiver Holding's AZN Position: Q1 2026 in Review

Optiver Holding opened a new position in AstraZeneca (AZN) in Q1 2026: 95,433 shares worth $18.8M. The stake represents 0.01% of the portfolio and ranks #287 among its holdings. This is a return to the name: Optiver Holding previously reported a position in AZN as recently as Q3 2025.

Optiver Holding first reported a position in AZN in Q1 2021 and has held it in 14 quarters since. The position peaked at $72.9M in Q4 2023. 1,377 funds tracked by Wall St. Rank hold AZN as of Q1 2026.

  • Optiver Holding held 95,433 shares of AstraZeneca worth $18.8M as of Q1 2026.
  • AstraZeneca was a new Optiver Holding position in Q1 2026.
  • AstraZeneca made up 0.01% of Optiver Holding's portfolio in Q1 2026, its #287 holding.
  • Optiver Holding first reported a position in AstraZeneca in Q1 2021 and has held it in 14 quarters since.
  • Optiver Holding's AstraZeneca position peaked at $72.9M in Q4 2023.
  • 1,377 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2026.

Based on Optiver Holding's 13F filing for Q1 2026, filed 15 May 2026.